JD Supra5h
Red Dye No 3: Old Data Induces New Ban
On January 16, 2025 the federal Food and Drug Administration (FDA) issued notice requiring manufacturers to reformulate their products removing ...
Managed Healthcare Executive8h
FDA Approves Metastatic Breast Cancer Drug, Datroway
The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
Which foods contain Red 3, the dye now banned by the FDA?
A colorful ingredient you may find in your pantry or medicine cabinet is now banned by the Food and Drug Administration.
JD Supra9h
FDA Bans the Use of Red No. 3 in Food and Ingested Drugs
On January 16, the U.S. Food and Drug Administration (FDA) announced that it is revoking the authorization for use of FD&C Red No. 3 in ...
Potential cancer breakthrough as terminal patients see tumors shrink or stop growing after being treated with a virus
Scientists in China have developed a modified virus that causes cancer cells to make sugars normally found in pigs, causing ...
Fact Check: Rise in under-50s cancer diagnoses predates COVID-19 vaccines
Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...
Cure Today14h
The Significance of the Subcutaneous Opdivo FDA Approval in Solid Tumors
Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means ...
RFK Jr. wants to improve Americans’ health. Here’s some advice from the outgoing FDA chief
Robert F. Kennedy Jr. has big plans for the FDA if he's confirmed as Secretary of Health and Human Services. FDA Commissioner ...
Daily18h
AstraZeneca-Daiichi Sankyo Datroway gets USFDA nod for previously treated Metastatic HR Positive, HER2 Negative Breast Cancer
Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the ...
ThePrint19h
2nd ‘living drug’ against blood cancer gets regulatory nod. All about Qartemi, made in India
Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...
Pharmaceutical Technology19h
FDA approves Amgen’s combo therapy for colorectal cancer
Amgen’s LUMAKRAS and Vectibix combination has received approval from the US FDA for treating KRAS G12C-mutated mCRC.
Medscape20h
FDA Approves Sotorasib + Panitumumab for mCRC
In the CodeBreaK 300 trial, sotorasib and panitumumab had better response rates and improved PFS vs standard-of-care ...